Patent application number | Description | Published |
20080312321 | THERAPEUTIC SUBSTITUTED CYCLOPENTANES - Therapeutic compounds are disclosed herein. | 12-18-2008 |
20090124676 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY - Disclosed herein are compounds having a formula: | 05-14-2009 |
20090186885 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas | 07-23-2009 |
20090239869 | THERAPEUTIC SUBSTITUTED CYCLOPENTANES - Therapeutic compounds are disclosed herein. Methods, compositions, and medicaments related thereto are also disclosed. The compounds described herein are used to treat ocular conditions, bowel disease and baldness. | 09-24-2009 |
20090270387 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS - Compounds comprising | 10-29-2009 |
20090275646 | THERAPEUTIC COMPOUNDS - Compounds having a structure | 11-05-2009 |
20090281104 | Therapeutic Compounds - Compounds comprising | 11-12-2009 |
20100137347 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS - Disclosed herein is a compound of the formula (I). Therapeutic methods, compositions, and medicaments, related thereto are also disclosed. | 06-03-2010 |
20100173981 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof, medicaments for the treatment of glaucoma or ocular hypertension and compositions related thereto, as further elaborated herein. | 07-08-2010 |
20100317872 | THERAPEUTIC COMPOUNDS - A compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl ring, wherein said compound has an EC | 12-16-2010 |
20110082184 | CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-HETEROARYLALKENYL DERIVATIVES AS THERAPEUTIC AGENTS - A compound comprising | 04-07-2011 |
20110112166 | THERAPEUTIC CYCLOPENTANE DERIVATIVES - Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein B, Y, and A are as described in claims | 05-12-2011 |
20110130439 | CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-HETEROARYLALKENYL DERIVATIVES AS THERAPEUTIC AGENTS - A compound comprising | 06-02-2011 |
20110152255 | THERAPEUTIC COMPOUNDS - Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein J, B, Y, and A are as described in claims | 06-23-2011 |
20110152328 | Combination Therapy For Glaucoma - Disclosed herein is method of treating glaucoma or ocular hypertension comprising administering a prostaglandin agonist and a second therapeutically active agent to a mammal in need thereof, wherein said second therapeutically active agent is selected from: β-Blockers, Adrenergic Agonists, non-selective adrenergic agonists, α2-selective adrenergic agonists, Carbonic Anhydrase Inhibitors, Cholinergic Agonists, direct acting cholinergic agonists, chlolinesterase inhibitors, Glutamate Antagonists, Ca | 06-23-2011 |
20110172435 | Treatment Of Inflammatory Bowel Disease - Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I | 07-14-2011 |
20110190286 | THERAPEUTICALLY ACTIVE CYCLOPENTANES - Disclosed herein are compounds having a formula: | 08-04-2011 |
20140235681 | Combination therapy for glaucoma - Disclosed herein is method of treating glaucoma or ocular hypertension comprising administering a prostaglandin agonist and a second therapeutically active agent to a mammal in need thereof, wherein said second therapeutically active agent is selected from: β-Blockers, Adrenergic Agonists, non-selective adrenergic agonists, α | 08-21-2014 |
20140323510 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS - Disclosed herein is a compound of the formula | 10-30-2014 |
20140357705 | SUBSTITUTED CYCLOPENTENES AS THERAPEUTIC AGENTS - Disclosed herein are compounds having a formula: | 12-04-2014 |
20150018400 | TREATMENT OF INFLAMMATORY BOWEL DISEASE - Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula I | 01-15-2015 |